Securities Registration
搜索文档
Adlai Nortye(ANL) - Prospectus(update)
2023-08-15 04:28
As filed with the Securities and Exchange Commission on August 14, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Adlai Nortye Ltd. (Exact name of Registrant as specified in its charter) Allen C. Wang, Esq. Michael E. Sullivan, Esq. Latham & Watkins LLP 18th Floor, One Exchange Square 8 Connaught Place Central, Hong Kong +852 2912 2500 (State or other jurisdiction of incorporation or organizatio ...
T Stamp (IDAI) - Prospectus(update)
2023-08-11 23:07
As filed with the U.S. Securities and Exchange Commission on August 11, 2023 Registration No. 333-272343 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 T STAMP INC. (Exact name of registrant as specified in its charter) Gareth Genner c/o T Stamp Inc. 3017 Bolling Way NE, Floors 1 and 2, Atlanta, Georgia, 30305, USA (404) 806-9906 Delaware 7372 20-2222203 (State or other jurisdiction of incorporation ...
Sacks Parente Golf(SPGC) - Prospectus(update)
2023-08-02 05:29
Registration Statement No. 333-266610 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 9 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SACKS PARENTE GOLF, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Delaware 3949 82-4938288 (I.R.S. Employer Identification Number) Sacks Parente Golf, Inc. 551 Calle San Pablo Camarillo, CA 93012 833-776-6659 If ...
MIRA Pharmaceuticals(MIRA) - Prospectus(update)
2023-07-26 05:09
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MIRA PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) Florida (State or other jurisdiction of incorporation or organization) As filed with the Securities and Exchange Commission on July 25, 2023 Registration No. 333-273024 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 4 TO FORM S-1 2834 (Primary Standard Industrial Classification Code Number) 85-3354547 (I.R.S. Employer Identification ...
Fitell (FTEL) - Prospectus(update)
2023-07-21 23:09
As filed with the Securities and Exchange Commission on July 21, 2023 Registration Statement No. 333-267778 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 7 to FORM F-1 FITELL CORPORATION (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) REGISTRATION STATEMENT (Exact name of registrant as specified in its charter) UNDER THE SECURITIES ACT OF 1933 Cayman Islands 3949 Not Applicable (I.R.S. Employer Id ...
Chromocell Therapeutics(CHRO) - Prospectus(update)
2023-07-20 09:15
As filed with the Securities and Exchange Commission on July 19, 2023 Registration No. 333-269188 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Amendment No. 4 to Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CHROMOCELL THERAPEUTICS CORPORATION (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 2836 86-3335449 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 4400 ...
Cheetah Net Supply Chain Service (CTNT) - Prospectus(update)
2023-07-19 09:05
As filed with the U.S. Securities and Exchange Commission on July 18, 2023 Registration No. 333-271185 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AMENDMENT NO. 5 TO (Name, address, including zip code, and telephone number, including area code, of agent for service) With a Copy to: CHEETAH NET SUPPLY CHAIN SERVICE INC. (Exact name of registrant as specified in its charter) | North Carolina | 5010 | 81-3509120 | | -- ...
Bionexus Gene Lab (BGLC) - Prospectus(update)
2023-07-15 07:20
As filed with the Securities and Exchange Commission on July 14, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1/A REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BIONEXUS GENE LAB CORP. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Registration No. 333-269753 (Primary Standard Industrial Classification Code Number) Wyoming 8071 35-2604830 (I.R.S. Employer Identification N ...
Microbot Medical(MBOT) - Prospectus(update)
2023-07-15 03:03
As filed with the Securities and Exchange Commission on July 14, 2023 Registration No. 333-273207 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MICROBOT MEDICAL INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) Delaware 2836 94-3078 ...
Rail Vision(RVSN) - Prospectus(update)
2023-07-14 02:50
股权交易 - 2020年10月,公司向克诺尔 - 布雷姆斯发行51,282股A类优先股,每股195美元,投资分两期支付[17] - 公司获500万美元认股权,2022年2月14日起分两期行使,2022年3月31日200万美元、6月30日228.6万美元,首次公开募股结束时到期[17] - 2022年3月6日,公司向克诺尔 - 布雷姆斯发行10,256股A类优先股,每股195美元,首次公开募股完成前,61,538股A类优先股自动转换为2,707,672股普通股[17] - 2020年1月19日,公司授予以色列铁路公司购买195,448股普通股认股权证,2023年1月25日其行使,公司发行195,448股普通股[18] - 2022年1月,公司与两名股东签总额100万美元未来股权简单协议,首次公开募股时转换为242,131股普通股和购买242,131股普通股的认股权证[20] 期权情况 - 2020年6月1日以来,公司按期权计划授予员工等购买总计1,929,762股普通股期权,行使价格1.85 - 6.14美元/股[19] - 截至2023年6月30日,473,530份期权到期,629,989份已归属[19] 文件提交 - 公司修订后的公司章程于2022年3月24日提交[21] - 公司修订的股份期权计划于2022年9月13日修订,2023年3月23日提交[21] - 公司与克诺尔 - 布雷姆斯多份协议2020 - 2021年签署,2022年3月24日提交[21] - 证券购买协议等文件于2023年5月11 - 15日提交[21] - 配售代理协议于2023年5月10日签署,5月11日提交[21] 注册声明 - 注册声明任何含招股说明书的生效后修订视为新注册声明[23] - 证券发行数量和价格变化不超有效注册声明中规定最高总发行价格20%,可按规则424(b)提交招股说明书反映变化[23] - 注册声明于2023年7月13日由公司相关人员签署[27] - 美国授权代表于2023年7月13日签署注册声明[28] - 公司证明符合F - 1表格提交要求,2023年7月13日在以色列拉阿南那提交注册声明[25]